• linkedin
  • Increase Font
  • Sharebar

    Urology Times names three to Editorial Council

    Jeffrey Kaufman, MDJeffrey E. Kaufman, MD Arthur L. Burnett, II, MD, MBAArthur L. Burnett, II, MD, MBA Barry A. Kogan, MDBarry A. Kogan, MD

    Urology Times has appointed three expert urologists to its Editorial Council: Jeffrey E. Kaufman, MD, Arthur L. Burnett, II, MD, MBA, and Barry A. Kogan, MD.

    Read: Upfront chemo called ‘standard’ in hormone-naïve PCa

    Dr. Kaufman, a private practitioner in Santa Ana, CA, will represent the area of health policy/socioeconomics. Dr. Burnett, professor of urology at Johns Hopkins Medicine, Baltimore, will oversee our coverage of sexual dysfunction. Dr. Kogan, chief of urology at Albany Medical Center, Albany, NY, will serve as our expert in pediatric urology.

    “I expect the knowledge base and leadership that Drs. Kaufman, Burnett, and Kogan bring to the field will help Urology Times maintain its position as the top-read urology publication in the United States,” said Richard R. Kerr, Urology Times’ content channel director. “We are honored to have them in our fold.”

    Urology Times also extends its gratitude and appreciation to William F. Gee, MD, John J. Mulcahy, MD, PhD, Howard M. Snyder, III, MD, and Anthony J. Schaeffer, MD, who recently stepped down from the Editorial Council after many years of dedicated, loyal service.

    Have you read:

    Overactive bladder: Two drugs found better than one

    Metformin/statin combo therapy reduces PCa mortality

    Despite warnings, mesh use for prolapse on the rise

    To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.

    Benjamin P. Saylor
    Saylor is content managing editor for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available